IBD drug therapies and COVID-19

Study code
DAA042

Lead researcher
Nick Kennedy

Study type
Data only

Institution or company
Cambridge University Hospitals NHS Foundation Trust

Researcher type
Non-commercial

Speciality area
Gastroenterology, Infection